金山科研平台，产品价格货期咨询微信：jinshanbio Source:Chinese Hamster Ovary cell line, CHO-derived Accession #:Q12918 N-terminal Sequence Analysis:Met-Asp Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:45 kDa SDS-PAGE:58-70 kDa, reducing conditions Activity:Measured by its binding ability in a functional ELISA.When RecombinantHuman CD161 FcChimerais coated at 5 µg/mL (100µL/well), the concentration of recombinant human CLEC-2A FcChimerathat produces 50%optimal binding response is found to be approximately2-10 µg/mL. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: CD161 Aliases: CD161; CLEC5B; KLRB1; Klrb1c; Ly59; NK1.1; NKR; NKRP1; NKRP1A Entrez Gene IDs: 3820 (Human); 17059 (Mouse) Background: CD161 CD161, also known as KLRB1, NK1.1, and NKR-P1A is a 40 kDa type II transmembrane glycoprotein that contains one C-type lectin domain in its extracellular region. CD161 is expressed as a disulfide-linked dimer on the surface of Th17 cells and NK cells as well as on subsets of CD1-restricted T cells, intestinal NT cells, peripheral memory T cells, monocytes, and dendritic cells. It binds to OCIL/CLEC2d, leading to an inhibition of NK cell-mediated cytotoxicity and IFN-gamma secretion. Alternatively, CD161 can enhance TCR activation to CD1d ligation. CD161+ cell populations are depleted in ulcerative colitis, Grave's disease, and AIDS, although CD161+ T cells are activated during asthmatic attacks. Additional related proteins are expressed in mouse but not human: the inhibitory NKR-P1B and D, and the stimulatory NKR-P1A, C, and F.